AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
75.29
+4.09 (5.74%)
Apr 25, 2024, 11:09 AM EDT - Market open
AstraZeneca Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 5,840 | 6,166 | 6,329 | 7,832 | 5,369 | 4,831 | 3,324 | 5,018 | 6,240 | 6,360 | Upgrade
|
Short-Term Investments | 122 | 239 | 69 | 160 | 849 | 849 | 1,230 | 884 | 613 | 795 | Upgrade
|
Cash & Cash Equivalents | 5,962 | 6,405 | 6,398 | 7,992 | 6,218 | 5,680 | 4,554 | 5,902 | 6,853 | 7,155 | Upgrade
|
Cash Growth | -6.92% | 0.11% | -19.94% | 28.53% | 9.47% | 24.73% | -22.84% | -13.88% | -4.22% | -28.54% | Upgrade
|
Receivables | 12,929 | 11,356 | 10,539 | 7,742 | 6,501 | 6,089 | 5,856 | 5,474 | 7,529 | 8,344 | Upgrade
|
Inventory | 5,424 | 4,699 | 8,983 | 4,024 | 3,193 | 2,890 | 3,035 | 2,334 | 2,143 | 1,960 | Upgrade
|
Other Current Assets | 739 | 133 | 324 | -214 | -349 | 932 | -295 | -448 | -518 | -762 | Upgrade
|
Total Current Assets | 25,054 | 22,593 | 26,244 | 19,544 | 15,563 | 15,591 | 13,150 | 13,262 | 16,007 | 16,697 | Upgrade
|
Property, Plant & Equipment | 10,502 | 9,449 | 10,171 | 8,917 | 8,335 | 7,421 | 7,615 | 6,848 | 6,413 | 6,010 | Upgrade
|
Long-Term Investments | 1,677 | 1,142 | 1,237 | 1,147 | 1,459 | 922 | 1,036 | 826 | 543 | 561 | Upgrade
|
Goodwill and Intangibles | 58,137 | 59,127 | 62,489 | 32,792 | 32,501 | 33,666 | 38,013 | 39,244 | 34,446 | 32,531 | Upgrade
|
Other Long-Term Assets | 5,749 | 4,172 | 5,222 | 4,329 | 3,519 | 3,051 | 3,540 | 2,346 | 2,647 | 2,796 | Upgrade
|
Total Long-Term Assets | 76,065 | 73,890 | 79,119 | 47,185 | 45,814 | 45,060 | 50,204 | 49,264 | 44,049 | 41,898 | Upgrade
|
Total Assets | 101,119 | 96,483 | 105,363 | 66,729 | 61,377 | 60,651 | 63,354 | 62,526 | 60,056 | 58,595 | Upgrade
|
Accounts Payable | 25,034 | 23,310 | 23,871 | 21,869 | 20,278 | 19,611 | 19,481 | 19,974 | 19,120 | 19,877 | Upgrade
|
Current Debt | 5,400 | 5,542 | 1,893 | 2,386 | 2,010 | 1,754 | 2,247 | 2,307 | 916 | 2,446 | Upgrade
|
Other Current Liabilities | 108 | -2,559 | -3,170 | -3,948 | -4,171 | -5,073 | -5,345 | -7,025 | -5,167 | -4,993 | Upgrade
|
Total Current Liabilities | 30,542 | 26,293 | 22,594 | 20,307 | 18,117 | 16,292 | 16,383 | 15,256 | 14,869 | 17,330 | Upgrade
|
Long-Term Debt | 23,222 | 23,690 | 28,888 | 17,994 | 16,217 | 17,359 | 15,560 | 14,501 | 14,137 | 8,397 | Upgrade
|
Other Long-Term Liabilities | 8,189 | 9,442 | 14,594 | 12,790 | 12,447 | 12,956 | 14,769 | 16,100 | 12,541 | 13,222 | Upgrade
|
Total Long-Term Liabilities | 31,411 | 33,132 | 43,482 | 30,784 | 28,664 | 30,315 | 30,329 | 30,601 | 26,678 | 21,619 | Upgrade
|
Total Liabilities | 61,953 | 59,425 | 66,076 | 51,091 | 46,781 | 46,607 | 46,712 | 45,857 | 41,547 | 38,949 | Upgrade
|
Total Debt | 28,622 | 29,232 | 30,781 | 20,380 | 18,227 | 19,113 | 17,807 | 16,808 | 15,053 | 10,843 | Upgrade
|
Debt Growth | -2.09% | -5.03% | 51.04% | 11.81% | -4.64% | 7.33% | 5.94% | 11.66% | 38.83% | 4.50% | Upgrade
|
Retained Earnings | 1,502 | -574 | 1,710 | 5,299 | 2,812 | 5,683 | 8,221 | 8,140 | 11,834 | 13,029 | Upgrade
|
Shareholders' Equity | 39,143 | 37,037 | 39,268 | 15,622 | 13,127 | 12,468 | 14,960 | 14,854 | 18,490 | 19,627 | Upgrade
|
Net Cash / Debt | -22,660 | -22,827 | -24,383 | -12,388 | -12,009 | -13,433 | -13,253 | -10,906 | -8,200 | -3,688 | Upgrade
|
Net Cash Per Share | -14.51 | -14.63 | -17.09 | -9.43 | -9.23 | -10.60 | -10.46 | -8.61 | -6.48 | -2.92 | Upgrade
|
Working Capital | -5,488 | -3,700 | 3,650 | -763 | -2,554 | -701 | -3,233 | -1,994 | 1,138 | -633 | Upgrade
|
Book Value Per Share | 12.63 | 11.96 | 13.85 | 5.95 | 5.04 | 4.92 | 5.91 | 5.87 | 7.31 | 7.78 | Upgrade
|